bioRxivCancer BiologyPreprint
Senescence triggers intracellular acidification and lysosomal alkalinization via ATP6AP2 attenuation in breast cancer cells
W. Li, K. Kawaguchi, S. Tanaka, C. He, Y. Maeshima, E. Suzuki, M. Toi
Abstract
Several chemotherapy drugs induce the senescence of cancer cells; however, the mechanism underlying intracellular pH dysregulation in senescent cells remains unclear. Adenosine triphosphatase H+ transporting accessory protein 2 (ATP6AP2) plays a critical role in maintaining pH homeostasis in cellular compartments. We here report a new function of ATP6AP2 in senescent breast cancer cells induced by doxorubicin and abemaciclib treatment. ATP6AP2 expression was significantly downregulated in senescent cells, leading to aberrant pH levels that impaired lysosome function and caused immune response changes. The drugs caused cell cycle arrest and proliferation suppression through the upregulation of senescence-related genes. Additionally, senescent cells showed altered inflammatory and immune transcriptional profiles by reprogramming the senescence-associated secretory phenotype. These findings suggest that ATP6AP2-mediated pH regulation during therapy-induced senescence may be linked to immune changes in senescent cancer cells. These findings provide novel insights into understanding the cellular mechanisms underlying the response to anti-cancer drugs.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lipocalin 2 upregulation mediates the detrimental effects of therapy-induced senescence in breast cancer cells.
J. Morales-Valencia, L. Lau, … G. David·bioRxiv·Mar 8, 2022
- Targeting therapy-induced senescence across multiple breast cancer subtypes in a metastatic bone-like microenvironment
Eleane C.B. Hamburger, Saber Ghazizadeh Darband, … Derek Hadar Rosenzweig·bioRxiv·May 17, 2026
- Targeting breast cancer senescence in 3D models of bone metastasis
Eleane C.B. Hamburger, Mansoureh Mohseni Garakani, … Derek Hadar Rosenzweig·Breast CancerPeer-reviewed·Apr 10, 2026
- Pharmacological CDK4/6 inhibitors promote senescence-associated lysosomal alterations and enhance sensitivity to lysosomotropic agents in breast cancer
Jamil Nehme, Sjors Maassen, … Marco Demaria·The EMBO JournalPeer-reviewed·Feb 10, 2025
- Dual Role of Cx43 in Enhancing CDK4/6 Inhibitor Response and Promoting the Elimination of Therapy-Induced Senescent Tumor Cells
Paula Carpintero-Fernández, Marta Barturen-Gómez, … María D. Mayán·bioRxiv·Oct 28, 2026
- Pharmacological CDK4/6 inhibition unravels a p53-induced secretory phenotype in senescent cells
B. Wang, S. Brandenburg, … M. Demaria·bioRxiv·Jun 5, 2020